Effects of sotatercept on lung diffusion capacity and blood gases in patients with pulmonary arterial hypertension

Karen M Olsson; Jan Fuge; Da-Hee Park; Jan C Kamp; Torben Brod; Britta Harrigfeld; Jonas C Schupp; Marius M Hoeper

doi:10.1183/13993003.01070-2023

Effects of sotatercept on lung diffusion capacity and blood gases in patients with pulmonary arterial hypertension

Eur Respir J. 2023 Aug 3;62(2):2301070. doi: 10.1183/13993003.01070-2023. Print 2023 Aug.

Authors

Karen M Olsson^{1

2

3}, Jan Fuge^{1

2

3}, Da-Hee Park^{1

2}, Jan C Kamp^{1

2}, Torben Brod^{1

2}, Britta Harrigfeld^{1

2}, Jonas C Schupp^{1

2}, Marius M Hoeper^{4

2}

Affiliations

¹ Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany.
² Member of the German Center for Lung Research (DZL), Biomedical Research in Endstage and Obstructive Lung Disease Hanover (BREATH), Hannover, Germany.
³ These authors contributed equally to this work.
⁴ Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany hoeper.marius@mh-hannover.de.

PMID: 37474157
DOI: 10.1183/13993003.01070-2023

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Familial Primary Pulmonary Hypertension
Gases
Humans
Lung
Pulmonary Arterial Hypertension*
Recombinant Fusion Proteins

Substances

ACE-011
Recombinant Fusion Proteins
Gases